Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: A pilot randomised controlled trial (PD COMM pilot)

被引：29

作者：

Sackley C.M. ^{[1
]}

Smith C.H. ^{[2
]}

Rick C.E. ^{[3
]}

Brady M.C. ^{[4
]}

Ives N. ^{[3
,23
]}

Patel S. ^{[3
,23
]}

Woolley R. ^{[3
,23
]}

Dowling F. ^{[3
,23
]}

Patel R. ^{[5
]}

Roberts H. ^{[6
]}

Jowett S. ^{[7
,24
]}

Wheatley K. ^{[8
,23
]}

Kelly D. ^{[9
]}

Sands G. ^{[11
]}

Clarke C.E. ^{[7
,10
]}

Molloy S. ^{[12
]}

Pavel C. ^{[12
]}

Rowbottom C. ^{[12
]}

Tweedie E. ^{[12
]}

Clarke P.C. ^{[13
]}

Nicholl D. ^{[13
]}

Siddiqui F. ^{[13
]}

Kanakaratna C. ^{[13
]}

Bennett R. ^{[13
]}

Blachford K. ^{[13
]}

Boughey A. ^{[13
]}

Harrison T. ^{[13
]}

Basso M.N. ^{[13
]}

Pooler J. ^{[13
]}

Round J. ^{[13
]}

Smith A. ^{[13
]}

Waszkiewicz C. ^{[13
]}

Raw J. ^{[14
]}

Vassallo J. ^{[14
]}

Ansari A. ^{[14
]}

Birtwell K. ^{[14
]}

Brooke J. ^{[14
]}

Finnigan K. ^{[14
]}

Gillan N. ^{[14
]}

Johnson E. ^{[14
]}

Jowitt H. ^{[14
]}

Kennedy A. ^{[14
]}

Buccoliero R. ^{[15
]}

Isles C. ^{[15
]}

Meredith S. ^{[15
]}

Stemp C. ^{[15
]}

Ware L. ^{[15
]}

Cooper S. ^{[16
]}

Appleton S. ^{[16
]}

Durman H. ^{[16
]}

机构：

[1] King's College London, Faculty of Life Sciences and Medicine, London

[2] University College London, Division of Psychology and Language Science, Faculty of Brain Sciences, London

[3] University of Birmingham, Birmingham Clinical Trials Unit (BCTU), Birmingham

[4] Glasgow Caledonian University, Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow

[5] Parkinson's UK West Midlands Regional Branch, London

[6] University of Southampton, Faculty of Medicine, London

[7] University of Birmingham, Institute for Applied Health Research, Birmingham

[8] University of Birmingham, Cancer Research UK Clinical Trials Unit (CRCTU), Birmingham

[9] University of East Anglia, School of Rehabilitation Sciences, Norwich

[10] Sandwell and West Birmingham Hospitals NHS Trust, Department of Neurology, Clinical Neurology City Hospital, Dudley Road, Birmingham

[11] School of Health Sciences, University of Nottingham, Nottingham

来源：

Pilot and Feasibility Studies | / 4卷 / 1期

关键词：

Parkinson's disease; Pilot randomised controlled trial; Speech and language therapy;

D O I：

10.1186/s40814-017-0222-z

中图分类号：

学科分类号：

摘要：

Background: Speech-related problems are common in Parkinson's disease (PD), but there is little evidence for the effectiveness of standard speech and language therapy (SLT) or Lee Silverman Voice Treatment (LSVT LOUD®). Methods: The PD COMM pilot was a three-arm, assessor-blinded, randomised controlled trial (RCT) of LSVT LOUD®, SLT and no intervention (1:1:1 ratio) to assess the feasibility and to inform the design of a full-scale RCT. Non-demented patients with idiopathic PD and speech problems and no SLT for speech problems in the past 2 years were eligible. LSVT LOUD® is a standardised regime (16 sessions over 4 weeks). SLT comprised individualised content per local practice (typically weekly sessions for 6-8 weeks). Outcomes included recruitment and retention, treatment adherence, and data completeness. Outcome data collected at baseline, 3, 6, and 12 months included patient-reported voice and quality of life measures, resource use, and assessor-rated speech recordings. Results: Eighty-nine patients were randomised with 90% in the therapy groups and 100% in the control group completing the trial. The response rate for Voice Handicap Index (VHI) in each arm was ≥ 90% at all time-points. VHI was highly correlated with the other speech-related outcome measures. There was a trend to improvement in VHI with LSVT LOUD® (difference at 3 months compared with control: - 12.5 points; 95% CI - 26.2, 1.2) and SLT (difference at 3 months compared with control: - 9.8 points; 95% CI - 23.2, 3.7) which needs to be confirmed in an adequately powered trial. Conclusion: Randomisation to a three-arm trial of speech therapy including a no intervention control is feasible and acceptable. Compliance with both interventions was good. VHI and other patient-reported outcomes were relevant measures and provided data to inform the sample size for a substantive trial. © 2018 The Author(s).

引用

共 50 条

[41] Microjet wound therapy versus sharp debridement on wound size reduction: a pilot randomised controlled trial
Probst, Sebastian
Saini, Camille
JOURNAL OF WOUND CARE, 2024, 33 (05)
[42] Randomised controlled clinical trial of standard versus echocardiographically guided ibuprofen treatment for patent ductus arteriosus in preterm infants: a pilot study
Carmen Bravo, Maria
Cabanas, Fernando
Riera, Joan
Perez-Fernandez, Elia
Quero, Jose
Perez-Rodriguez, Jesus
Pellicer, Adelina
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (09): : 904 - 909
[43] Effectiveness of remotely delivered speech therapy in persons with Parkinson's disease - a randomised controlled trial
Maas, Janna J. L.
de Vries, Nienke M.
Inthout, Joanna
Bloem, Bastiaan R.
Kalf, Johanna G.
ECLINICALMEDICINE, 2024, 76
[44] Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson's Disease-A Pilot study
Pillai, Kanchana
Goyal, Vinay
Srivastava, Achal
Rajan, Roopa
Srivastava, Padma
Radhakrishnan, Divya Madathiparambi
Singh, Mamta Bhushan
Vishnu, V. Y.
Elavarasi, Arunmozhimaran
NEUROLOGY, 2021, 96 (15)
[45] Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial
Scolari, Francesco
Dallera, Nadia
Gesualdo, Loreto
Santoro, Domenico
Pani, Antonello
Santostefano, Marisa
Feriozzi, Sandro
Mani, Laila-Yasmin
Boscutti, Giuliano
Messa, Piergiorgio
Magistroni, Riccardo
Quaglia, Marco
Ponticelli, Claudio
Ravani, Pietro
BMJ OPEN, 2019, 9 (12):
[46] Erratum to: Cognitive rehabiliation for Parkinson’s disease dementia: a study protocol for a pilot randomised controlled trial
John V. Hindle
Tamlyn J. Watermeyer
Julie Roberts
Anthony Martyr
Huw Lloyd-Williams
Andrew Brand
Petra Gutting
Zoe Hoare
Rhiannon Tudor Edwards
Linda Clare
Trials, 18
[47] A randomised controlled trial and economic evaluation of direct versus indirect and individual versus group modes of speech and language therapy for children with primary language impairment
Boyle, J.
McCartney, E.
Forbes, J.
O'Hare, A.
HEALTH TECHNOLOGY ASSESSMENT, 2007, 11 (25) : 1 - +
[48] A Computerized Cognitive Behavioral Therapy Randomized, Controlled, Pilot Trial for Insomnia in Parkinson's Disease (ACCO-PD Study)
Patel, Shnehal
Ahmed, Anwar
Foldvary-Schaefer, Nancy
Ojo, Oluwadamilola
Genc, Gencer
Oravivattanakul, Srivadee
Fernandez, Hubert
NEUROLOGY, 2016, 86
[49] A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson's disease (The ACCORD-PD study)
Patel, S.
Ojo, O.
Genc, G.
Wang, L.
Benab, J.
Drerup, M.
Foldvary, N.
Ahmed, A.
Fernandez, H. H.
MOVEMENT DISORDERS, 2016, 31 : S125 - S125
[50] ADVANCED RECOVERY ROOM CARE VERSUS STANDARD OF CARE IN LIVING DONOR KIDNEY TRANSPLANTATION: A PILOT RANDOMISED CONTROLLED TRIAL
Venkataraman, Karthik
Collins, Michael
Ludbrook, Guy
Coates, Toby
NEPHROLOGY, 2023, 28 : 95 - 96

← 1 2 3 4 5 →